Smithwood Advisers’s Pfizer PFE Stock Holding History

Smithwood Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,054,000	Closed	-$29.6M	–	27
2014 Q3	$29.6M	Buy	+1,054,000	New	+$29.6M	1.9%	18

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Smithwood Advisers's PFE Position: Q4 2014 in Review

Smithwood Advisers sold out of Pfizer (PFE) in Q4 2014, closing a stake of 1,054,000 shares — an estimated $29.6M sold.

Smithwood Advisers first reported a position in PFE in Q3 2014 and held it in 1 quarter. The position peaked at $29.6M in Q3 2014. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

Smithwood Advisers reported no remaining Pfizer position as of Q4 2014 after selling out during the quarter.
Smithwood Advisers sold 1,054,000 Pfizer shares in Q4 2014, an estimated $29.6M.
Smithwood Advisers first reported a position in Pfizer in Q3 2014 and held it in 1 quarter.
Smithwood Advisers's Pfizer position peaked at $29.6M in Q3 2014.
1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Smithwood Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.